Sublingual immunotherapy in children with asthma: A population-based register study.

ABSTRACT:

Background

Daily sublingual immunotherapy (SLIT) for 3 years reduces symptoms of allergic disease and induces tolerance. Real-life data from children with asthma receiving SLIT are scarce.

Objective

We used population-based data to describe characteristics, SLIT duration, and changes in morbidity in children with asthma prescribed SLIT.

Methods

The study included children (5-17 years) with asthma who were prescribed SLIT, and who were registered in the Swedish National Airway Register (SNAR) before SLIT initiation (N = 1,514), of whom 782 had post-SLIT recordings in the SNAR. Age, sex, Asthma Control Test score (≤19 denotes uncontrolled asthma), spirometry data, number of SLIT tablets dispensed, and socioeconomic background were extracted from the SNAR and other natio

SUBMITTER: Konradsen JR 

PROVIDER: S-EPMC12581690 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature